CERVARIX - Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant
Navigation: NDC > Supplier starting with: G > GLAXOSMITHKLINE BIOLOGICALS SA| Field | Value |
|---|---|
| NDC Code: | 58160-830 |
| Proprietary Name: | CERVARIX |
| Suffix: | |
| Non-Proprietary Name: | Human Papillomavirus Bivalent (Types 16 and 18) Vaccine, Recombinant |
| Dosage Form: | INJECTION, SUSPENSION |
| Method: | INTRAMUSCULAR |
| Original Marketing Date: | 16-10-2009 |
| Category Name: | BLA |
| Application Number: | BLA125259 |
| Labeler: | GLAXOSMITHKLINE BIOLOGICALS SA |
| Substance Name: | HUMAN PAPILLOMAVIRUS TYPE 16 L1 CAPSID PROTEIN RESIDUES 2-471 ANTIGEN; HUMAN PAPILLOMAVIRUS TYPE 18 L1 CAPSID PROTEIN RESIDUES 2-472 ANTIGEN |
| Active Numerator Strength: | 20; 20 |
| Active Ingredient Unit: | ug/.5mL; ug/.5mL |
| Pharm Classes: | |
| DEA Schedule: |